Show simple item record

dc.contributor.authorMurray, J
dc.contributor.authorHilbig, A
dc.contributor.authorSoe, TT
dc.contributor.authorEi, WLSS
dc.contributor.authorSoe, KP
dc.contributor.authorCiglenecki, I
dc.date.accessioned2020-12-05T17:08:33Z
dc.date.available2020-12-05T17:08:33Z
dc.date.issued2020-11-13
dc.date.submitted2020-12-04
dc.identifier.urihttp://hdl.handle.net/10144/619803
dc.description.abstractBackground Cytomegalovirus retinitis (CMVR) is an opportunistic infection in HIV-infected people. Intraocular or intravenous ganciclovir was gold standard for treatment; however, oral valganciclovir replaced this in high-income countries. Low- and middle-income countries (LMIC) frequently use intraocular injection of ganciclovir (IOG) alone because of cost. Methods Retrospective review of all HIV-positive patients with CMVR from February 2013 to April 2017 at a Médecins Sans Frontièrs HIV clinic in Myanmar. Treatment was classified as local (IOG) or systemic (valganciclovir, or valganciclovir and IOG). The primary outcome was change in visual acuity (VA) post-treatment. Mortality was a secondary outcome. Results Fifty-three patients were included. Baseline VA was available for 103 (97%) patient eyes. Active CMVR was present in 72 (68%) eyes. Post-treatment, seven (13%) patients had improvement in VA, 30 (57%) had no change, and three (6%) deteriorated. Among patients receiving systemic therapy, four (12.5%) died, compared with five (24%) receiving local therapy (p = 0.19). Conclusions Our results from the first introduction of valganciclovir for CMVR in LMIC show encouraging effectiveness and safety in patients with advanced HIV. We urge HIV programmes to include valganciclovir as an essential medicine, and to include CMVR screening and treatment in the package of advanced HIV care.en_US
dc.language.isoenen_US
dc.publisherBMCen_US
dc.rightsWith thanks to BMC.en_US
dc.titleTreating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected dataen_US
dc.identifier.journalBMC Infectious Diseasesen_US
refterms.dateFOA2020-12-05T17:08:33Z


Files in this item

Thumbnail
Name:
Murray et al 2020 Treating ...
Size:
721.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record